Giant biogene holding co
WebGiant Biogene General Information. Description. Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant … WebApr 11, 2024 · Company Profile 02367. Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the …
Giant biogene holding co
Did you know?
WebGIANT BIOGENE HOLDING CO., LTD. : Revenue and Earnings Analysts Forecasts Revisions 2367 KYG3887G1091 MarketScreener Homepage Equities Hong Kong … WebNov 4, 2024 · It is the second largest professional skin treatment product company in China in 2024 with a retail sales value of RMB6.0 billion as well as the largest collagen-based professional skin treatment product company by retail sales in China. The offering, which closed on 4 November 2024, raised approximately HK$495.8 million.
WebNov 28, 2024 · Giant Biogene Holding Company Limited is engaged in the research, development, manufacture and sale of bioactive material-based beauty and health products. The Company's main products include functional skincare products and medical dressings. The company was established in 2024 and is headquartered in Hong Kong, China. … WebApr 6, 2024 · Giant Biogene Holding Co Ltd is a China-based investment holding company. The Company is principally engaged the research, development, …
WebGiant Biogene Holding Co., Ltd. (2367.HK) Stock Historical Prices & Data - Yahoo Finance Giant Biogene Holding Co., Ltd. (2367.HK) HKSE - HKSE Delayed Price. Currency in HKD Follow 46.600... WebOct 25, 2024 · Oct 24, 202420:31. China's Giant Biogene Holding Co Ltd launched on Tuesday an initial public offering (IPO) in Hong Kong to raise up to $80 million, a term sheet showed, sharply lower than its original target of $500 million amid a major sell-off in equity markets. The Xian-based company, which specialises in medicinal skin care treatment, …
WebApr 6, 2024 · 시장 통찰력 보고서에서 발행한 글로벌 의료용 콜라겐 스폰지 시장 조사 보고서는 주요 플레이어, 국가, 제품 유형 및 최종 산업의 관점에서 전 세계 및 주요 지역의 현재 전망 을 발견 합니다 . 이 보고서는 세계 시장의 최고 기업을 연구하고 시장을 …
WebMar 28, 2024 · We've established that Giant Biogene Holding maintains its high P/E on the strength of its forecast growth being higher than the wider market, as expected. At this stage investors feel the potential for a deterioration in earnings isn't … eltax コロナ 延長申請WebGIANT BIOGENE HOLDING CO., LTD. (2367) Add to my list. Report. Delayed Hong Kong Stock Exchange - 04:08:31 2024-04-06 am EDT. 47.65. HKD. eltax コロナ 延長WebSee the company profile for Giant Biogene Holding Co., Ltd. (2367.HK) including business summary, industry/sector information, number of employees, business summary, corporate governance, key ... eltax エラー 問い合わせWebApr 3, 2024 · Future criteria checks 0/6. Giant Biogene Holding is forecasted to grow earnings and revenue by 32.7% and 29.9% per annum respectively. EPS and ROE are also expected to grow by 27.6% and 29.8% per year respectively. Analyst coverage for Giant Biogene Holding stock is good. eltax システムエラー mca061eWebGiant Biogene Holding Co., Ltd. (2367.HK) HKSE - HKSE Delayed Price. Currency in HKD Follow 47.600 -2.550 (-5.08%) At close: 04:08PM HKT Show: Income Statement Balance Sheet Cash Flow Annual... eltax お問い合わせ 電話番号WebMar 29, 2024 · Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People’s Republic of China. About the company Rewards Trading at 6% below our estimate of its fair value Earnings are forecast to grow 32.88% … eltax サーバWeb2367 Complete Giant Biogene Holding Co. Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. eltax コロナ 延長 確定申告